Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of lea... Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. 더 보기
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results PR Newswire REDWOOD CITY, Calif., Jan. 13, 2025 Cash, Cash Equivalents and Short-Term Investments...
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif., Dec. 17, 2024 REDWOOD CITY, Calif., Dec. 17, 2024 /PRNewswire/ -- Nevro Corp. (NYSE:...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.19 | 35.2071005917 | 3.38 | 4.57 | 3.165 | 992979 | 4.00885433 | CS |
4 | 0.98 | 27.2980501393 | 3.59 | 4.57 | 3.165 | 585806 | 3.8700963 | CS |
12 | -0.33 | -6.73469387755 | 4.9 | 6.85 | 3.165 | 598892 | 4.42048202 | CS |
26 | -5.5 | -54.6176762661 | 10.07 | 10.37 | 3.165 | 594556 | 5.34151665 | CS |
52 | -13.39 | -74.5545657016 | 17.96 | 19.47 | 3.165 | 556405 | 8.52970288 | CS |
156 | -86.42 | -94.9774700517 | 90.99 | 90.99 | 3.165 | 567200 | 28.58818229 | CS |
260 | -119.63 | -96.3204508857 | 124.2 | 188.14 | 3.165 | 517157 | 63.58062478 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관